Article
Genetic Susceptibility for Atrial Fibrillation in Patients Undergoing Atrial Fibrillation Ablation.
Circulation. Arrhythmia and electrophysiology - 1 Mar 2020
Shoemaker M Benjamin, Husser Daniela, Roselli Carolina, Al Jazairi Meelad, Chrispin Jonathan, Kühne Michael, Neumann Benjamin, Knight Stacey, Sun Han, Mohanty Sanghamitra, Shaffer Christian, Thériault Sébastien, Rinke Lauren Lee, Siland Joylene E, Crawford Diane M, Ueberham Laura, Zardkoohi Omeed, Büttner Petra, Geelhoed Bastiaan, Blum Steffen, Aeschbacher Stefanie, Smith Jonathan D, Van Wagoner David R, Freudling Rebecca, Müller-Nurasyid Martina, Montgomery Jay, Yoneda Zachary, Wells Quinn, Issa Tariq, Weeke Peter, Jacobs Victoria, Van Gelder Isabelle C, Hindricks Gerhard, Barnard John, Calkins Hugh, Darbar Dawood, Michaud Greg, Kääb Stefan, Ellinor Patrick, Natale Andrea, Chung Mina, Nazarian Saman, Cutler Michael J, Sinner Moritz F, Conen David, Rienstra Michiel, Bollmann Andreas, Roden Dan M, Lubitz Steven
Abstract excerpt
BACKGROUND: Ablation is a widely used therapy for atrial fibrillation (AF); however, arrhythmia recurrence and repeat procedures are common. Studies examining surrogate markers of genetic susceptibility to AF, such as family history and individual AF susceptibility alleles, suggest these may be associated with recurrence outcomes. Accordingly, the aim of this study was to test the association between AF genetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.